ZTS
Zoetis Inc - Ordinary Shares - Class A

3,575
Loading...
Loading...
News
all
press releases
Zoetis (ZTS) Surpasses Market Returns: Some Facts Worth Knowing
Zoetis (ZTS) concluded the recent trading session at $143.5, signifying a +1.68% move from its prior day's close.
Zacks·2d ago
News Placeholder
More News
News Placeholder
Zoetis (ZTS) Stock Declines While Market Improves: Some Information for Investors
In the closing of the recent trading day, Zoetis (ZTS) stood at $146.25, denoting a -1.32% move from the preceding trading day.
Zacks·13d ago
News Placeholder
Zoetis Gains CVMP Backing for Portela, Eyes EU Approval in Cat OA Pain
ZTS secures CVMP's positive opinion recommending the approval of Portela, a long-acting OA pain therapy for cats, with final decision expected in late 2025.
Zacks·13d ago
News Placeholder
Zoetis (ZTS) Stock Sinks As Market Gains: Here's Why
Zoetis (ZTS) reached $149.79 at the closing of the latest trading day, reflecting a -1.29% change compared to its last close.
Zacks·19d ago
News Placeholder
If You Invested $1000 in Zoetis a Decade Ago, This is How Much It'd Be Worth Now
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Zacks·1mo ago
News Placeholder
SDZNY or ZTS: Which Is the Better Value Stock Right Now?
SDZNY vs. ZTS: Which Stock Is the Better Value Option?
Zacks·1mo ago
News Placeholder
SDZNY vs. ZTS: Which Stock Is the Better Value Option?
SDZNY vs. ZTS: Which Stock Is the Better Value Option?
Zacks·2mo ago
News Placeholder
Why Zoetis (ZTS) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·2mo ago
News Placeholder
ZTS Q2 Earnings & Revenues Beat Estimates, '25 Outlook Raised
Zoetis posts better-than-expected Q2 results with rising sales of pet medicines, boosting its 2025 outlook.
Zacks·2mo ago
News Placeholder
Zoetis (ZTS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Zoetis (ZTS) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks·2mo ago

Latest ZTS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.